Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Sex Transm Dis. 2019 May;46(5):312–316. doi: 10.1097/OLQ.0000000000000968

Table 2.

Cumulative vaginal sex during follow-up, by week and dose*

Day Cumulative vaginal sexual
intercourse since treatment
Total cohort
7 17/86 (19.8%)
14 35/89 (39.3%)
21 44/89 (49.4%)
28 54/89 (60.7%)
Single dose
7 11/52 (21.2%)
14 25/54 (46.3%)
21 34/54 (63.0%)
28 40/54 (74.1%)
7-day dose
7 6/34 (17.6%)
14 10/35 (28.6%)
21 10/35 (28.6%)
28 14/35 (40.0%)
*

Women self-reported either condom use or that both she and her partner(s) had been treated before sexual intercourse.